Interleukin-22 attenuates renal tubular cells inflammation and fibrosis induced by TGF-β1 through Notch1 signaling pathway

References

• Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684–696.
   PubMed Web of Science ®Google Scholar
• Humphreys BD. Mechanisms of renal fibrosis. Annu Rev Physiol. 2018;80:309–326.
   PubMed Web of Science ®Google Scholar
• Gewin LS. Renal fibrosis: primacy of the proximal tubule. Matrix Biol. 2018;68–69:248–262.
   PubMed Web of Science ®Google Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144–158.
   PubMed Web of Science ®Google Scholar
• Kooman JP, Dekker MJ, Usvyat LA, et al. Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol. 2017;313:F938–F950.
   PubMed Web of Science ®Google Scholar
• Impellizzeri D, Esposito E, Attley J, et al. Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD). Pharmacol Res. 2014;81:91–102.
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–338.
   PubMed Web of Science ®Google Scholar
• McGaraughty S, Davis-Taber RA, Zhu CZ, et al. Targeting anti-TGF-β therapy to fibrotic kidneys with a dual specificity antibody approach. J Am Soc Nephrol. 2017;28:3616–3626.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Liu J, Peng Y, et al. GSTA3 attenuates renal interstitial fibrosis by inhibiting TGF-beta-induced tubular epithelial-mesenchymal transition and fibronectin expression. PLoS One. 2016;11:e0160855.
   PubMed Web of Science ®Google Scholar
• Kretzler M, Allred L. Notch inhibition reverses kidney failure. Nat Med. 2008;14:246–247.
   PubMed Web of Science ®Google Scholar
• Edeling M, Ragi G, Huang S, et al. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol. 2016;12:426–439.
   PubMed Web of Science ®Google Scholar
• Henrique D, Schweisguth F. Mechanisms of Notch signaling: a simple logic deployed in time and space. Development. 2019;146:dev172148.
   PubMed Web of Science ®Google Scholar
• Luca VC, Kim BC, Ge C, et al. Notch-Jagged complex structure implicates a catch bond in tuning ligand sensitivity. Science. 2017;355:1320–1324.
   PubMed Web of Science ®Google Scholar
• Morrissey J, Guo G, Moridaira K, et al. Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol. 2002;13:1499–1508.
   PubMed Web of Science ®Google Scholar
• Nyhan KC, Faherty N, Murray G, et al. Jagged/Notch signaling is required for a subset of TGFβ1 responses in human kidney epithelial cells. Biochim Biophys Acta. 2010;1803:1386–1395.
   PubMed Web of Science ®Google Scholar
• Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009;10:857–863.
   PubMed Web of Science ®Google Scholar
• Peng C, Zhang S, Lei L, et al. Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis. Sci Rep. 2017;7:44172.
   PubMed Web of Science ®Google Scholar
• Gronke K, Hernández PP, Zimmermann J, et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature. 2019;566:249–253.
   PubMed Web of Science ®Google Scholar
• Nagao-Kitamoto H, Leslie JL, Kitamoto S, et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med. 2020.
   PubMed Web of Science ®Google Scholar
• Kulkarni OP, Hartter I, Mulay SR, et al. Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J Am Soc Nephrol. 2014;25:978–989.
   PubMed Web of Science ®Google Scholar
• Weidenbusch M, Song S, Iwakura T, et al. IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis. Physiol Rep. 2018; 6:e13817.
   PubMed Web of Science ®Google Scholar
• Tian YC, Phillips AO. TGF-beta1-mediated inhibition of HK-2 cell migration. J Am Soc Nephrol. 2003;14:631–640.
   PubMed Web of Science ®Google Scholar
• Ho LC, Sung JM, Shen YT, et al. Egr-1 deficiency protects from renal inflammation and fibrosis. J Mol Med. 2016;94:933–942.
   PubMed Web of Science ®Google Scholar
• Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest. 2010;120:4040–4054.
   PubMed Web of Science ®Google Scholar
• Iwakura T, Zhao Z, Marschner JA, et al. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration. Nephrol Dial Transplant. 2019;34:1669–1680.
   PubMed Web of Science ®Google Scholar
• Wang Y, Briz V, Chishti A, et al. Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR- mediated neurodegeneration. J Neurosci. 2013;33:18880–18892.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Tang J, Guo H, et al. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nat Med. 2016;22:906–914.
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte E, Witte K, et al. Biology of interleukin-22. Semin Immunopathol. 2010;32:17–31.
   PubMed Web of Science ®Google Scholar
• Tang PM, Zhang YY, Mak TS, et al. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs. J Physiol. 2018;596:3493–3503.
   PubMed Web of Science ®Google Scholar
• Niranjan T, Bielesz B, Gruenwald A, et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med. 2008;14:290–298.
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10:493–503.
   PubMed Web of Science ®Google Scholar
• Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747–785.
   PubMed Web of Science ®Google Scholar
• Xiao C, Zhou Q, Li X, et al. Differentiation and recruitment of IL-22-producing helper T cells in lgA nephropathy. Am J Transl Res. 2016;8:3872–3882.
   PubMed Web of Science ®Google Scholar
• Gan L, Zhou Q, Li X, et al. Intrinsic renal cells induce lymphocytosis of Th22 cells from IgA nephropathy patients through B7-CTLA-4 and CCL-CCR pathways. Mol Cell Biochem. 2018;441:191–199.
   PubMed Web of Science ®Google Scholar
• Xiao C, Zhou Q, Li X, et al. Losartan and Dexamethasone may inhibit chemotaxis to reduce the infiltration of Th22 cells in IgA nephropathy. Int Immunopharmacol. 2017;42:203–208.
   PubMed Web of Science ®Google Scholar
• Ye J, Ji Q, Liu J, et al. Interleukin 22 promotes blood pressure elevation and endothelial dysfunction in angiotensin II-treated mice. J Am Heart Assoc. 2017;6:e005875.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Y, Fan J, et al. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation. Cell Death Dis. 2017;8:e2937.
   PubMed Web of Science ®Google Scholar
• Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov. 2014;13:21–38.
   PubMed Web of Science ®Google Scholar
• Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50:871–891.
   PubMed Web of Science ®Google Scholar
• Huang R, Zhou Q, Veeraragoo P, et al. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect. Ren Fail. 2011;33:207–216.
   PubMed Web of Science ®Google Scholar